Will it keep me awake? Common caffeine intake habits and sleep in real life situations
Sleep Medicine, Psychopharmacology, Clinical Pharmacology and seminar by Hans-Peter Landolt, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland; Sleep & Health Zurich, University Center of Competence, University of Zürich, Zürich, Switzerland
Hosted by NeuroLeman Network
Friday 13:00–14:10 Zurich (GMT+2)
Ended
Abstract
Daily caffeine consumption and chronic sleep restriction are highly prevalent in society. It is well established that acute caffeine intake under controlled conditions enhances vigilance and promotes wakefulness but can also delay sleep initiation and reduce electroencephalographic (EEG) markers of sleep intensity, particularly in susceptible individuals. To investigate whether these effects are also present during chronic consumption of coffee/caffeine, we recently conducted several complementary studies. We examined whether repeated coffee intake in dose and timing mimicking ‘real world’ habits maintains simple and complex attentional processes during chronic sleep restriction, such as during a busy work week. We found in genetically caffeine-sensitive individuals that regular coffee (300 mg caffeine/day) benefits most attentional tasks for 3-4 days when compared to decaffeinated coffee. Genetic variants were also used in the population-based HypnoLaus cohort, to investigate whether habitual caffeine consumption causally affects time to fall asleep, number of awakenings during sleep, and EEG-derived sleep intensity. The multi-level statistical analyses consistently showed that sleep quality was virtually unaffected when >3 caffeine-containing beverages/day were compared to 0-3 beverages/day. This conclusion was further corroborated by quantifying the sleep EEG in the laboratory in habitual caffeine consumers. Compared to placebo, daily intake of 3 x 150 mg caffeine over 10 days did not strongly impair nocturnal sleep nor subjective sleep quality in good sleepers. Finally, we tested whether an engineered delayed, pulsatile-release caffeine formula can improve the quality of morning awakening in sleep-restricted volunteers. We found that 160 mg caffeine taken at bedtime ameliorated the quality of awakening, increased positive and reduced negative affect scores, and promoted sustained attention immediately upon scheduled wake-up. Such an approach could prevent over-night caffeine withdrawal and provide a proactive strategy to attenuate disabling sleep inertia. Taken together, the studies suggest that common coffee/caffeine intake habits can transiently attenuate detrimental consequences of reduced sleep virtually without disturbing subjective and objective markers of sleep quality. Nevertheless, coffee/caffeine consumption cannot compensate for chronic sleep restriction.
Topics
Related seminars
- Video · 1 h 6 min · Nov 20, 2021Thomas Andrillon, Paris Brain Institute
Location, time and type of epileptic activity influence how sleep modulates epilepsy
Video · 58 min · Oct 11, 2023Birgit Frauscher, Duke
More from NeuroLeman Network
All talksDevelopmental emergence of personality
Dec 10, 2025Bassem HassanA human stem cell-derived organoid model of the trigeminal ganglion
Dec 8, 2025Oliver HarschnitzSpike train structure of cortical transcriptomic populations in vivo
Oct 29, 2025Kenneth Harris